<DOC>
	<DOC>NCT02726971</DOC>
	<brief_summary>This single-center,prospective,randomized,controlled trial is conducted to evaluate the efficacy of different doses of estrogen artificial periodic therapy after hysteroscopic adhesiolysis in patients with moderate-severe adhesion.</brief_summary>
	<brief_title>Comparison of Different Doses of Oestrogen Therapy for Preventing Intrauterine Adhesion</brief_title>
	<detailed_description />
	<mesh_term>Tissue Adhesions</mesh_term>
	<mesh_term>Gynatresia</mesh_term>
	<mesh_term>Dydrogesterone</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>1. Moderate and severe IUA according to the AFS IU adhesion scoring system (AFS 1988 version) (19) showed in Table1 (AFS scoreâ‰¥5); 2. Scheduled for hysteroscopic adhesiolysis; 3. Agreed to have two followup hysteroscopy; and 4. Written, informed consent obtained. 1. Received estrogen therapy within 3 months of enrollment; 2. Suffering from leiomyoma, polyps, cancer, or polycystic ovarian syndrome (PCOS); 3. History of genital tuberculosis; and 4. Contraindication for estrogen therapy.</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Intrauterine Adhesion</keyword>
	<keyword>Oestrogen Artificial Periodic Therapy</keyword>
</DOC>